Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-026472·Sio Gene Therapies Inc.
Schedule 13D ownership disclosure
AXOVANT SCIENCES LTD
Security class unavailable · CUSIP: G0750W104
Event date: 2020-02-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 18,577,380
- Percent of class
- 47.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-026472
- Form type
- SC 13D/A
- Filer
- Sio Gene Therapies Inc.
- CIK
- CIK 1636050
- Filed
- Feb 28, 2020
- Reporting period
- Feb 24, 2020
- Description
- Schedule 13D beneficial ownership